These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 21281430)

  • 1. Effect of mutant β-catenin on liver growth homeostasis and hepatocarcinogenesis in transgenic mice.
    Stein TJ; Jochem A; Holmes KE; Sandgren EP
    Liver Int; 2011 Mar; 31(3):303-12. PubMed ID: 21281430
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lack of tumorigenesis in the mouse liver after adenovirus-mediated expression of a dominant stable mutant of beta-catenin.
    Harada N; Miyoshi H; Murai N; Oshima H; Tamai Y; Oshima M; Taketo MM
    Cancer Res; 2002 Apr; 62(7):1971-7. PubMed ID: 11929813
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Minimal cooperation between mutant Hras and c-myc or TGFα in the regulation of mouse hepatocyte growth or transformation in vivo.
    Stein TJ; Bowden M; Sandgren EP
    Liver Int; 2011 Oct; 31(9):1298-305. PubMed ID: 22093452
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mutant Hras(G12V) and Kras(G12D) have overlapping, but non-identical effects on hepatocyte growth and transformation frequency in transgenic mice.
    Figueiredo ML; Stein TJ; Jochem A; Sandgren EP
    Liver Int; 2012 Apr; 32(4):582-91. PubMed ID: 22221894
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Shp2 deletion in hepatocytes suppresses hepatocarcinogenesis driven by oncogenic β-Catenin, PIK3CA and MET.
    Liu JJ; Li Y; Chen WS; Liang Y; Wang G; Zong M; Kaneko K; Xu R; Karin M; Feng GS
    J Hepatol; 2018 Jul; 69(1):79-88. PubMed ID: 29505847
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epidermal growth factor receptor: a novel target of the Wnt/beta-catenin pathway in liver.
    Tan X; Apte U; Micsenyi A; Kotsagrelos E; Luo JH; Ranganathan S; Monga DK; Bell A; Michalopoulos GK; Monga SP
    Gastroenterology; 2005 Jul; 129(1):285-302. PubMed ID: 16012954
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phenotype of single hepatocytes expressing an activated version of β-catenin in liver of transgenic mice.
    Schreiber S; Rignall B; Braeuning A; Marx-Stoelting P; Ott T; Buchmann A; Hammad S; Hengstler JG; Schwarz M; Köhle C
    J Mol Histol; 2011 Oct; 42(5):393-400. PubMed ID: 21822615
    [TBL] [Abstract][Full Text] [Related]  

  • 8. c-Myc and transforming growth factor α enhance the development of hepatic lesions due to mutant β-catenin in transgenic mice.
    Jochem AS; Holmes KE; Stein TJ
    Comp Med; 2014 Oct; 64(5):351-9. PubMed ID: 25402175
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Activation of Wnt/beta-catenin pathway during hepatocyte growth factor-induced hepatomegaly in mice.
    Apte U; Zeng G; Muller P; Tan X; Micsenyi A; Cieply B; Dai C; Liu Y; Kaestner KH; Monga SP
    Hepatology; 2006 Oct; 44(4):992-1002. PubMed ID: 17006939
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The transcription factor c-Jun protects against liver damage following activated β-Catenin signaling.
    Trierweiler C; Blum HE; Hasselblatt P
    PLoS One; 2012; 7(7):e40638. PubMed ID: 22792392
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Activation of beta-catenin during hepatocarcinogenesis in transgenic mouse models: relationship to phenotype and tumor grade.
    Calvisi DF; Factor VM; Loi R; Thorgeirsson SS
    Cancer Res; 2001 Mar; 61(5):2085-91. PubMed ID: 11280770
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Zonation of heme synthesis enzymes in mouse liver and their regulation by β-catenin and Ha-ras.
    Braeuning A; Schwarz M
    Biol Chem; 2010 Nov; 391(11):1305-13. PubMed ID: 20707599
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pegylated interferon alpha targets Wnt signaling by inducing nuclear export of β-catenin.
    Thompson MD; Dar MJ; Monga SP
    J Hepatol; 2011 Mar; 54(3):506-12. PubMed ID: 21093092
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phenotype and growth behavior of residual β-catenin-positive hepatocytes in livers of β-catenin-deficient mice.
    Braeuning A; Singh Y; Rignall B; Buchmann A; Hammad S; Othman A; von Recklinghausen I; Godoy P; Hoehme S; Drasdo D; Hengstler JG; Schwarz M
    Histochem Cell Biol; 2010 Nov; 134(5):469-81. PubMed ID: 20886225
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tumor promotion and inhibition by phenobarbital in livers of conditional Apc-deficient mice.
    Braeuning A; Gavrilov A; Geissler M; Wenz C; Colnot S; Templin MF; Metzger U; Römer M; Zell A; Schwarz M
    Arch Toxicol; 2016 Jun; 90(6):1481-94. PubMed ID: 26838046
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genetic ablation of β-catenin inhibits the proliferative phenotype of mouse liver adenomas.
    Singh Y; Port J; Schwarz M; Braeuning A
    Br J Cancer; 2014 Jul; 111(1):132-8. PubMed ID: 24874479
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hepatomegaly in transgenic mice expressing an oncogenic form of beta-catenin.
    Cadoret A; Ovejero C; Saadi-Kheddouci S; Souil E; Fabre M; Romagnolo B; Kahn A; Perret C
    Cancer Res; 2001 Apr; 61(8):3245-9. PubMed ID: 11309273
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Liver-targeted disruption of Apc in mice activates beta-catenin signaling and leads to hepatocellular carcinomas.
    Colnot S; Decaens T; Niwa-Kawakita M; Godard C; Hamard G; Kahn A; Giovannini M; Perret C
    Proc Natl Acad Sci U S A; 2004 Dec; 101(49):17216-21. PubMed ID: 15563600
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tbx3 is a downstream target of the Wnt/beta-catenin pathway and a critical mediator of beta-catenin survival functions in liver cancer.
    Renard CA; Labalette C; Armengol C; Cougot D; Wei Y; Cairo S; Pineau P; Neuveut C; de Reyniès A; Dejean A; Perret C; Buendia MA
    Cancer Res; 2007 Feb; 67(3):901-10. PubMed ID: 17283120
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Wnt/beta-catenin signaling activates and determines hepatic zonal expression of glutathione S-transferases in mouse liver.
    Giera S; Braeuning A; Köhle C; Bursch W; Metzger U; Buchmann A; Schwarz M
    Toxicol Sci; 2010 May; 115(1):22-33. PubMed ID: 20118494
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.